Navigation Links
Surgical Delivery of Drug Shows Promise Against 'Bleeding' Stroke
Date:2/7/2013

by about 5 percent a day for the standard-therapy patients.

Those in the tPA group had a quicker recovery and went home from the hospital an average of 38 days sooner than those in the standard-therapy group, resulting in estimated health care cost savings of $44,000 per patient, according to the study.

"This is the most promising treatment that has come along in the last 30 or 40 years for people who have suffered hemorrhagic stroke," study leader Dr. Daniel Hanley, a professor of neurology at Johns Hopkins, said in a university news release.

Hanley said the next step is to conduct a larger study of 500 patients in order to confirm the benefits of the tPA therapy.

For his part, Langer said he was cautiously optimistic about the therapy. "More work will be needed to fully understand the effects of these powerful drugs," he said, "but this preliminary work represents real progress in the development of safer treatment and management of these critically ill patients."

Another expert agreed.

"Up to now, hemorrhages deep in the brain have been hard to treat because surgery necessarily damages normal tissue to get to the blood clot," said Dr. Louis Cornacchia, director of neurosurgery at Brookdale University Hospital and Medical Center, in New York City. But the new catheter-based technique "not only allows more of the clot to be removed but also results in better outcomes for patients."

Cornacchia agreed that further, larger trials are needed to confirm the results. "However, if this study is validated, it will point the way to a standardized treatment of a common, very stubborn medical problem," he said.

The findings were scheduled for presentation Thursday at the annual meeting of the American Stroke Association in Honolulu. The study also will be published simultaneously in the journal Stroke.

More information

There's more on bleeding stroke at the

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Dental Diagnostic & Surgical Equipment Market is expected to grow at a CAGR of 5.8% & to reach $6,073.7 Million by 2016 - by MarketsandMarkets
2. Crown Valley Outpatient Surgical Center, one of the top ambulatory surgery centers in Orange County announces the launch of their new website
3. Dr. Andy Chiou elected President and Chief Executive Officer of Peoria Surgical Group, Ltd.
4. Surgical Supply Specialist Nouvelle Inc. Announces Products for Care of Traumatic Burns and Scars
5. Mexican Bariatric Surgeon Announces Limited Offer on Specials for Surgical Weight Loss Procedures
6. Surgical-site infections may increase risk of deadly blood clots after colorectal surgery
7. Mussels Stickiness Inspires Surgical Adhesive
8. Understanding brain tumor growth opens door for non-surgical treatment
9. Surgical technique spots cancer invasion with fluorescence
10. Three Surgeons of Los Angeles Colon and Rectal Surgical Associates Have Received the Prestigious 2013 Los Angeles SuperDoctors Award for the Second Year in a Row
11. The science of neurosurgical practice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Surgical Delivery of Drug Shows Promise Against 'Bleeding' Stroke
(Date:4/25/2015)... For thirteen years, the Twin Cities DI Day ... in the nation! This year, on May 5th, 2015, Secura ... take DI Day on the road by supporting the first ... RHU, DIA, CLTC, Chief Executive Officer at Secura Consultants and ... change by stating, "The first Twin Cities DI Day was ...
(Date:4/24/2015)... As the nation recognizes the Month of the ... young men and women, the “Alaska – Forget Me ... presents a special training session on Adverse Childhood Experiences ... understanding of the effect of childhood trauma and, in ... and military – who provide services and support to ...
(Date:4/24/2015)... 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... federal multidistrict litigation underway in U.S. District Court, ... the parties involved in the proceeding submitted a ... other things, preparation for the litigation’s upcoming bellwether ... plaintiffs and defendants have conducted depositions of non-party ...
(Date:4/24/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... auto insurance for senior citizens . , Senior ... does not mean that they cannot find affordable coverage. ... can find the right coverage for their cars at ... like http://lowcostcarinsuranceprice.com/ provides free leads from various ...
(Date:4/24/2015)... Olive Fertility Centre is proud to ... co-director, has been honoured for his pioneering work in ... Hope Gala. , “We are very pleased to ... has been at the forefront of fertility research and ... Executive Director of Fertile Futures--a Canadian non-profit organization that ...
Breaking Medicine News(10 mins):Health News:Secura Consultants Takes DI Day On The Road 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2
... This release is available in Spanish . ... acuity, between now and the year 2020, more and more ... age-related macular degeneration (AMD) and other sight-robbing diseases. ... Nutrition and Vision Research are finding that healthy eating can ...
... because of the potential to provide more durable and widespread ... cells. Now, researchers at Children,s Hospital Boston and their colleagues ... most common form of human lung cancer and, more significantly, ... tumor to tumor, depending upon the tumor,s genetic signature. ...
... , THURSDAY, July 1 (HealthDay News) -- ... uterine fibroids and helps women with the non-cancerous tumors ... pain and heavy menstrual bleeding, are a leading cause ... "Both the fibroids and the surgical interventions commonly used ...
... ... campaign is the first of its kind for designer and includes the ... cities across the country, national advertising, a bus wrap in Chicago, and ... colors and styles on July 8th, Vera Bradley is encouraging people across ...
... The Parkinson,s Disease Foundation (PDF) is pleased to announce ... understand the cause(s) of and find a cure for ... the work of 15 leading scientists and are provided ... and Research Fellowship Grants. The first program seeks ...
... ... Together to Share Ideas and Innovate , ... Braintree, MA (PRWEB) July 1, 2010 -- WorldAPP, a global on-demand web-application company, ... can come together to share ideas about all aspects of the data collection process. , ...
Cached Medicine News:Health News:Cancer stem cells are not 1 size fits all, lung cancer models show 2Health News:Drug May Shrink Fibroids, Preserve Fertility 2Health News:Vera Bradley Launches National “Be Colorful” Campaign 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 3Health News:WorldAPP Launches User Community 2Health News:WorldAPP Launches User Community 3
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... of the "Global Biobanking Market 2015-2019" report ... Global Biobanking market to grow at a CAGR of ... Biobanking market can be divided into two segments: Equipment ... the growth prospects of the Global Biobanking market for ...
(Date:4/24/2015)... 24, 2015 The National Institute of ... National Institutes of Health [NIH])  provided grants totaling ... for the development of diagnostic tests for antibiotic-resistant ... at U.S. health facilities , the NIAID and ... multiplexed and effective tests using alternative methods to ...
(Date:4/24/2015)... Hospira, Inc. (NYSE: HSP ... therapies, spoke about the importance of extrapolation in bringing ... (EGA) annual European Biosimilars Group conference in ... the publication of a pivotal white paper titled, ... of biosimilars." Speaking at the EGA ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7
... - Additional data reinforce long-term efficacy of ACTEMRA ... - , , , NUTLEY, N.J., June ... LITHE (Toci LI zumab Safety and THE ... greater proportion of rheumatoid arthritis (RA) patients treated with ...
... Issue of Circulation , , SILVER SPRING, Md. ... UTHR ) and Eli Lilly and Company ... of a pivotal 16-week study showing that a once-daily ... capacity and improved time to clinical worsening in patients ...
Cached Medicine Technology:Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 2Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 3Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 4Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 5Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 6Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 7Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients 8Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 2Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 3Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 4Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 5Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily 6
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies....
Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
... one-piece baseplate is designed specifically ... thicker than the current Assura, ... erosion for longer. The product ... piece and two piece, both ...
... kit for the screening of factor-V-related APC ... the test for the factor V:Q506 mutation ... with an excess of V-DEF Plasma bioreagent. ... discriminate between heterozygous and homozygous factor V ...
Medicine Products: